CMS Addresses Medicare Advantage Overpayments While Modernizing Technology and Reforming FDA Adverse Event Reporting
Today's developments reveal a healthcare system in technological transition, with significant financial and regulatory implications.
The $76 billion Medicare Advantage overpayment finding from MedPAC comes as CMS undergoes a major technological modernization, suggesting a push toward better…
The $76 billion Medicare Advantage overpayment finding from MedPAC comes as CMS undergoes a major technological modernization, suggesting a push toward better oversight and cost control in federal healthcare programs. Meanwhile, the FDA's launch of a unified adverse event reporting system signals a broader shift toward consolidated digital health surveillance. These changes, coupled with emerging challenges in telehealth mental health delivery and GLP-1 drug marketing oversi…
One pattern. Trace it.
- 01
A pattern worth naming
Watch for: 1) CMS technology modernization milestone announcements and implementation deadlines over next 90 days; 2) Industry response to MedPAC's Medicare Advantage findings and potential policy proposals; 3) Healthcare provider adoption rates of FDA's new unified adverse event system in first 60 days; 4) Congressional action on rural mental health access following telehealth findings; 5) Additional FDA guidance on telehealth prescribing practices, particularly for GLP-1 medications.
Ask your CFO whether the unit economics on every new service line still pencil under the new rate environment.
By Joseph Lancaster, Editor — with research from Pine Needle's intelligence layer.
The next argument lands tomorrow at 6 a.m. Pacific. Get it in your inbox →